CONvsCTN: Catheter Over Needle (CON) vs Catheter Through Needle (CTN).

Sponsor
Pontificia Universidad Catolica de Chile (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05960799
Collaborator
(none)
70
1
2
11
6.4

Study Details

Study Description

Brief Summary

This is a randomized clinical trial with the objective of comparing the time of insertion of two types of perineural catheters in shoulder surgery. These devices are thin lines that have to be inserted over a needle or throw a needle, depending of the type of catheter that is used. The hypothesis is: the installation of Contiplex C or catheter over needle (CON) is faster than a normal contiplex catheter or Catheter throw needle (CTN) at same rate of effectivity.

Condition or Disease Intervention/Treatment Phase
  • Device: CON - Contiplex C™ (CC)
  • Device: CTN - Contiplex
N/A

Detailed Description

In the market, there is currently two types of catheter to perform a continuous nerve block. One is called Contiplex throw needle catheter that is the most used device and other needle available for performing this block called the Contiplex® C Set, which uses a different method called Catheter over Needle (CON). This method involves advancing the catheter immediately along with the needle upon puncture, and once it reaches the target site, the needle inside the catheter is removed, leaving the catheter in its final working position. This eliminates the step of threading the catheter through the needle. Additionally, this technique allows for the visualization of the final catheter site in vivo with a single operator.

Considering the differences between both techniques, the hypothesis proposed in this study is that in adult patients undergoing shoulder and proximal humerus surgery requiring anesthetic/analgesic management with inter-scalene catheters, the use of the Catheter over Needle (CON) technique results in shorter installation time and similar effectiveness compared to the conventional technique of catheter insertion through the needle (CTN) with tunnel fixation.

The primary objectives will be to compare the block execution times between the CTN and CON techniques, as well as the effectiveness rate of both catheters

Study Design

Study Type:
Interventional
Anticipated Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized control trialRandomized control trial
Masking:
Single (Participant)
Masking Description:
A list of 72 names, corresponding 36 of them to contiplex C and 36 to regular contiplex will be randomized and will be introduced into sealed envelopes. Before, in order to perform the nerve block the anesthesist will open the envelope and will know wich is the catheter he has to use.
Primary Purpose:
Treatment
Official Title:
Randomizes Control Trial (RCT): Superiority Study on Inter Scalene Block Execution Time for Shoulder Traumatology Surgery and Non-inferiority for Effectiveness Between Two Block Methods: Catheter Over Needle (CON) vs Catheter Through Needle (CTN).
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Mar 31, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Contiplex C or CON

Patients who will receive a contiplex C block for interscalene nerve block. This catheter also calls Catheter over needle (CON), wich is a catheter that is inserted at the same time that the needle is advancing.

Device: CON - Contiplex C™ (CC)
This is a catheter used for peripherical nerve block that is inserted at the same time that the needle is being introduced. When the target is achieved, the needle is retired.

Active Comparator: Contiplex or CTN

Patients who will receive a regular contiplex block for interscalene nerve block or also called Catheter throw needle (CTN). This catheter is the gold standard in this centre and the mechanism of insertion is to introduce the catheter throw the needle.

Device: CTN - Contiplex
This is the traditional catheter used in this centre for peripheric nerve block. In this catheter the needle is introduced first. When the target is achieved the catheter is then introduced throw the needle and after that the needle is retired.

Outcome Measures

Primary Outcome Measures

  1. Time of insertion [During Procedure]

    The time from the insertion of the needle in the skin to: insertion of the catheter and fixation of the tegaderm in the skin

Secondary Outcome Measures

  1. Visual analogue scale (VAS). 0 (minimum) -10 (maximum) points on VAS scale. Lower scores means less pain and higher scores means more pain. [72 hours to determinate the VAS]

    compare both groups in terms of level of pain in VAS.

  2. Rate of accidental [72 hrs to evaluate the rate of accidental withdrawal]

    Accidental withdrawal is the accidental withdrawal of the catheter before 72 hrs after surgery

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients older than 18 years

  • Rotator cuff or proximal humerus surgery

  • ASA I-III

  • BMI 18-39 kg/m2

  • Acceptance of receiving a peripheric nerve block

Exclusion Criteria:
  • Inability to provide consent for the study

  • Coagulopathy

  • Sepsis

  • Severe Renal or hepatic disease (Creatinin > 2.0 or Child C)

  • Allergy to local anesthetics

  • Previous peripheral nerve damage

  • Refusal of postoperative continuous block technique

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital clinico UC christus Santiago de Chile Santiago Chile

Sponsors and Collaborators

  • Pontificia Universidad Catolica de Chile

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Alejandro Luengo, Clinical professor, Pontificia Universidad Catolica de Chile
ClinicalTrials.gov Identifier:
NCT05960799
Other Study ID Numbers:
  • 211124003
First Posted:
Jul 27, 2023
Last Update Posted:
Jul 27, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Alejandro Luengo, Clinical professor, Pontificia Universidad Catolica de Chile

Study Results

No Results Posted as of Jul 27, 2023